UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epidemic arboviral diseases: priorities for research and public health

The Lancet infectious diseases, 2017-03, Vol.17 (3), p.e101-e106

2017

Volltextzugriff (PDF)

Japanese Encephalitis: Risk of Emergence in the United States and the Resulting Impact

Viruses, 2023-12, Vol.16 (1), p.54

Monath, Thomas P

2023

Volltextzugriff (PDF)

Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential

PLoS pathogens, 2022-06, Vol.18 (6), p.e1010658

2022

Volltextzugriff (PDF)

Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses

Vaccine, 2010-01, Vol.28 (3), p.632-649

2010

Volltextzugriff (PDF)

The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever

The Lancet infectious diseases, 2011-08, Vol.11 (8), p.622-632

2011

Volltextzugriff (PDF)

A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants

The Journal of clinical investigation, 2022-05, Vol.132 (10), p.1-16

2022

Volltextzugriff (PDF)

Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study

The Lancet infectious diseases, 2017-08, Vol.17 (8), p.854-866

2017

Volltextzugriff (PDF)

Fever versus fever: The role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus

Infection, genetics and evolution, 2013-10, Vol.19, p.292-311

2013

Volltextzugriff (PDF)

Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease

Frontiers in immunology, 2023-09, Vol.14, p.1216225-1216225

2023

Volltextzugriff (PDF)

An Inactivated Cell-Culture Vaccine against Yellow Fever

The New England journal of medicine, 2011-04, Vol.364 (14), p.1326-1333

2011

Volltextzugriff (PDF)

rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessment

Vaccine: X, 2019-04, Vol.1, p.100009, Article 100009

2019

Volltextzugriff (PDF)

Introduction and Tribute to Charlie Calisher

Diseases, 2021-10, Vol.9 (4), p.75

2021

Volltextzugriff (PDF)

A Live, Attenuated Recombinant West Nile Virus Vaccine

Proceedings of the National Academy of Sciences - PNAS, 2006-04, Vol.103 (17), p.6694-6699

2006

Volltextzugriff (PDF)

Review of the risks and benefits of yellow fever vaccination including some new analyses

Expert review of vaccines, 2012-04, Vol.11 (4), p.427-448

Monath, Thomas P

2012

Volltextzugriff (PDF)

A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2

Emerging microbes & infections, 2022-12, Vol.11 (1), p.2724-2734

2022

Volltextzugriff (PDF)

A short history of Lassa fever: the first 10–15 years after discovery

Current opinion in virology, 2019-08, Vol.37, p.77-83

Monath, Thomas P

2019

Volltextzugriff (PDF)

Responding to the threat of urban yellow fever outbreaks

The Lancet infectious diseases, 2017-03, Vol.17 (3), p.248-250

2017

Volltextzugriff (PDF)

Preclinical and clinical development of a YFV 17 D-based chimeric vaccine against West Nile virus

Viruses, 2013-12, Vol.5 (12), p.3048-3070

2013

Volltextzugriff (PDF)

Vaccines against diseases transmitted from animals to humans: A one health paradigm

Vaccine, 2013-11, Vol.31 (46), p.5321-5338

Monath, Thomas P

2013

Volltextzugriff (PDF)

Vaccines to Prevent Coccidioidomycosis: A Gene-Deletion Mutant of Coccidioides Posadasii as a Viable Candidate for Human Trials

Journal of fungi (Basel), 2022-08, Vol.8 (8), p.838

2022

Volltextzugriff (PDF)

Chimeric Live, Attenuated Vaccine against Japanese Encephalitis (ChimeriVax-JE): Phase 2 Clinical Trials for Safety and Immunogenicity, Effect of Vaccine Dose and Schedule, and Memory Response to Challenge with Inactivated Japanese Encephalitis Antigen

The Journal of infectious diseases, 2003-10, Vol.188 (8), p.1213-1230

2003

Volltextzugriff (PDF)

ChimeriVax-West Nile Virus Live-Attenuated Vaccine: Preclinical Evaluation of Safety, Immunogenicity, and Efficacy

Journal of Virology, 2004-11, Vol.78 (22), p.12497-12507

2004

Volltextzugriff (PDF)

Yellow fever resurgence: An avoidable crisis?

npj vaccines, 2022-11, Vol.7 (1), p.137-137, Article 137

2022

Volltextzugriff (PDF)

The Origin of COVID-19 and Why It Matters

The American journal of tropical medicine and hygiene, 2020-09, Vol.103 (3), p.955-959

2020

Volltextzugriff (PDF)

1 – 25 von 312

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(280)
Mit Volltextzugriff
(221)

Publikationsform

Sprache

Englisch
(310)
Portugiesisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(196)
Life Sciences & Biomedicine
(190)
Humans
(144)
Animals
(128)
Infectious Diseases
(90)
Biological And Medical Sciences
(80)
Immunology
(77)
Microbiology
(72)
Female
(62)
Vaccines
(53)
Medical Sciences
(51)
Fundamental And Applied Biological Sciences. Psychology
(48)
Tropical Medicine
(45)
Virology
(45)
Adult
(43)
Male
(43)
Mice
(43)
Viral Diseases
(40)
Medicine, Research & Experimental
(39)
Research & Experimental Medicine
(39)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Epidemic arboviral diseases: priorities for research and public health

Japanese Encephalitis: Risk of Emergence in the United States and the Resulting Impact

Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential

Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses

The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever

A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants

Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study

Fever versus fever: The role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus

Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease

An Inactivated Cell-Culture Vaccine against Yellow Fever

rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessment

Introduction and Tribute to Charlie Calisher

A Live, Attenuated Recombinant West Nile Virus Vaccine

Review of the risks and benefits of yellow fever vaccination including some new analyses

A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2

A short history of Lassa fever: the first 10–15 years after discovery

Responding to the threat of urban yellow fever outbreaks

Preclinical and clinical development of a YFV 17 D-based chimeric vaccine against West Nile virus

Vaccines against diseases transmitted from animals to humans: A one health paradigm

Vaccines to Prevent Coccidioidomycosis: A Gene-Deletion Mutant of Coccidioides Posadasii as a Viable Candidate for Human Trials

Chimeric Live, Attenuated Vaccine against Japanese Encephalitis (ChimeriVax-JE): Phase 2 Clinical Trials for Safety and Immunogenicity, Effect of Vaccine Dose and Schedule, and Memory Response to Challenge with Inactivated Japanese Encephalitis Antigen

ChimeriVax-West Nile Virus Live-Attenuated Vaccine: Preclinical Evaluation of Safety, Immunogenicity, and Efficacy

Yellow fever resurgence: An avoidable crisis?

The Origin of COVID-19 and Why It Matters

Evaluation of humoral immune response after yellow fever infection: an observational study on patients from the 2017-2018 sylvatic outbreak in Brazil

Suchergebnisse filtern